
|Articles|May 15, 2004
Ophthalmic industry benefits from Pfizer acquisition, too
With Advanced Medical Optics' (AMO) acquisition of the Pfizer surgical sector, it bought a lot more than just products.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement




























